Subscribe
shutterstock_1625917948_nitpicker
nitpicker / Shutterstock.com
5 September 2023Big PharmaMuireann Bolger

Bayer targets Amazon sellers over fake products

Healthcare company accuses online sellers of selling unauthorised over-the-counter products | Consumers leave bad reviews after receiving damaged, expired and poor quality goods, says the complaint | Vory, Sater, Seymour and Pease.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Bayer begins $240m AI drug discovery project with Exscientia
10 January 2020   Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.
Big Pharma
Bayer sues over syringes used in CT scans
23 February 2021   Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
Bayer begins $240m AI drug discovery project with Exscientia
10 January 2020   Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.
Big Pharma
Bayer sues over syringes used in CT scans
23 February 2021   Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes.

More on this story

Big Pharma
Bayer begins $240m AI drug discovery project with Exscientia
10 January 2020   Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.
Big Pharma
Bayer sues over syringes used in CT scans
23 February 2021   Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York